Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Rockwell Medical, Inc. (NASDAQ: RMTI).

Full DD Report for RMTI

You must become a subscriber to view this report.


Recent News from (NASDAQ: RMTI)

Rockwell Medical's (RMTI) CEO Rob Chioini on Q1 2018 Results - Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q1 2018 Results Earnings Conference Call May 10, 2018 04:30 PM ET Executives Paul Arndt - MD, LifeSci Advisors Rob Chioini - Founder and CEO Tom Klema - CFO Ben Wolin - Chairman Ray Pratt - CMO Analysts David Bouchey - IFS Securities Pr...
Source: SeekingAlpha
Date: May, 10 2018 22:42
Rockwell Medical beats by $0.01, beats on revenue
Rockwell Medical (NASDAQ: RMTI ): Q1 EPS of -$0.13 beats by $0.01 . Revenue of $14.9M (+2.1% Y/Y) beats by $0.1M . Press Release More news on: Rockwell Medical, Inc., Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: May, 10 2018 16:16
Rockwell Medical Reports First Quarter 2018 Results
Conference call at 4:30 p.m. EDT today, May 10 WIXOM, Mich., May 10, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated specialty pharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and se...
Source: GlobeNewswire
Date: May, 10 2018 16:01
3 Things In Biotech, May 9: New AML Therapy Imminent? AVEO Hedges, Rockwell Boosts Iron
Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we're talking about! Here is some more information if you're curious . Welcome to another edition of "3 Things In Biotech You Should Learn Today," a...
Source: SeekingAlpha
Date: May, 10 2018 08:00
Rockwell Medical Update on Calcitriol New Manufacturing Submission to FDA
WIXOM, Mich., May 08, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), today provided an update on its new manufacturing submission for its Calcitriol vitamin D injection, stating that the FDA has provided a target date for a response to the submission of no later than August ...
Source: GlobeNewswire
Date: May, 08 2018 08:30
Rockwell Medical Schedules First Quarter 2018 Earnings Call
WIXOM, Mich., May 02, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of iron replacement, secondary hyperparathyr...
Source: GlobeNewswire
Date: May, 02 2018 11:10
Rockwell Medical Announces Triferic® Presentations at the 2018 International Congress on Peritoneal Dialysis
Conference to be held May 5-8, in Vancouver, Canada WIXOM, Mich., May 02, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), announced today that two Triferic ® abstracts have been selected for presentation at the 17 th Congress of the International Society for P...
Source: GlobeNewswire
Date: May, 02 2018 08:30
Research Report Identifies Rockwell Medical, Peoples, Cutera, Barrett Business Services, Cray, and Hawkins with Renewed Outlook - Fundamental Analysis, Calculating Forward Movement
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Rockwell Medical, Inc. (NASDAQ:RMTI), Peoples Bancorp Inc. (NASDAQ:PEBO), ...
Source: GlobeNewswire
Date: May, 01 2018 08:30
Blog Exposure - Impax Launched a Generic Version of Estrace(R) Cream
Stock Monitor: Rockwell Medical Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 10, 2018 / Active-Investors.com has just released a free research report on Impax Laboratories, Inc. (NASDAQ: IPXL ). If you want access to this report all you need to do is sign up now by click...
Source: ACCESSWIRE IA
Date: April, 10 2018 07:40
Rockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical Meetings
  Three Poster Presentations  with Data for Triferic Clinical Pharmacology and Peritoneal Dialysis Conference being held April 11-14 in Austin, TX WIXOM, Mich., April 05, 2018 (GLOBE NEWSWIRE) --  Rockwell Medical, Inc. (NASDAQ:RMTI), announced...
Source: GlobeNewswire
Date: April, 05 2018 08:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-175.926.076.115.81205,909
2018-01-055.876.106.135.82426,548
2018-01-045.865.875.905.72333,141
2018-01-035.655.806.155.65284,364
2018-01-025.825.645.945.55384,344

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-1857,063128,02344.5725Short
2018-05-1749,729104,92947.3930Short
2018-05-1653,123106,34549.9535Short
2018-05-1579,751200,83639.7095Short
2018-05-1444,52386,45551.4985Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on RMTI.


About Rockwell Medical, Inc. (NASDAQ: RMTI)

Logo for Rockwell Medical, Inc. (NASDAQ: RMTI)

Not available

 

Contact Information

 

 

Current Management

  • Robert L. Chioini / President, CEO
  • Thomas E. Klema / CFO, Secretary

Current Share Structure

  • Market Cap: $288,350,122 - 05/11/2018
  • Issue and Outstanding: 51,768,424 - 02/17/2018

 


Recent Filings from (NASDAQ: RMTI)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 19 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 21 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 15 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: March, 09 2018

 

 


Daily Technical Chart for (NASDAQ: RMTI)

Daily Technical Chart for (NASDAQ: RMTI)


Stay tuned for daily updates and more on (NASDAQ: RMTI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: RMTI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in RMTI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of RMTI and does not buy, sell, or trade any shares of RMTI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/